In this study, we demonstrated that membrane immunofluorescence (MIF) with canine erythrocytes is a much more sensitive diagnostic technique compared with the Coombs test to detect auto-antibodies on RBC. We also demonstrate how the evaluation of the MIF test can be made more precisely which results in a more clear interpretation. Till nowadays the Evans syndrome (combined thrombocytopenia and anemia) is not very well diagnosed in dogs. Only a few studies with low animal numbers tested auto-antibodies on RBC and thrombocytes. Here we describe the frequency of Evans syndrome based on the evaluation of a large data set with 557 dogs. The novelty of the thesis also lies in making a research of the amount of CICs in sera of AIHA/AITP patients is described as well as the cytotoxic potential of patient’s sera for canine leucocytes. These new aspects of diagnosis (AIHA) and pathogenesis (AIHA/AITP) are not only relevant for dogs but also for humans and can be used for better differential diagnosis in medicine. The new findings with respect to circulating immune complexes and cytotoxicity are also offer new therapeutic concepts. Besides, the study has resulted in the characterization of monoclonal antibodies which allow for the detection of so far undetectable canine differentiation antigens (CD molecules) on canine erythrocytes (CD235) and thrombocytes (CD42a). The identified mAbs are useful in the identification of relevant target structures for autoantibodies on these cells.

Introdução: O diagnóstico precoce de câncer de próstata (CaP) é essencial para aumentar a sobrevida dos pacientes, mas os marcadores e métodos atuais não possuem sensibilidade e especificidade suficientes, tornando o diagnóstico ainda muito impreciso. Recentemente, as células tumorais circulantes (CTCs) têm surgido não como método de rastreio do CaP, mas sim como marcadores de prognóstico utilizando um arsenal de diversos alvos para a captura dessas células. Contudo, a busca por um método ou marcadores comuns para o rastreio, diagnóstico, prognóstico e monitoramento da doença ainda se apresenta com um dos principais objetivos técnico-científicos a ser alcançado. Objetivo: apresentar um novo marcador, o aptâmero A4 selecionado previamente por 3DCell SELEX na linhagem PC3, e avaliar sua capacidade de detectar CTCs por citometria de fluxo no sangue de pacientes com CaP virgens de tratamento e sob diferentes regimes terapêuticos. Material e métodos: o estudo avaliou 34 homens com CaP e 16 homens sem alterações prostáticas. Foi coletado o sangue em tubo com EDTA, e após proceder a lise de hemácias, as células nucleadas de cada paciente foram incubadas com o aptâmero A4 conjugado à biotina, e em seguida lavadas e incubadas com estreptoavidina-FITC para posterior análise em citometria de fluxo. Os percentuais de CTCs foram comparados entre os dois grupos de pacientes e correlacionados com idade, níveis de PSA, estadiamento e procedimentos terapêuticos adotados (bloqueio hormonal, radioterapia e cirurgia). O limite de detecção acima de 1% de CTCs foi considerado positivo, utilizando como base o percentual observado em todos os 16 controles negativos. Resultados: todos os pacientes foram diagnosticados como positivos independentemente do tempo de terapia ou do estadiamento, exceto um paciente sob bloqueio hormonal que não apresentou CTCs. O percentual de CTCs apresentou alta correlação com idade (R=0,75) e com os níveis de PSA (R=0,80) de forma exponencial, embora seis pacientes com altos índices de células circulantes apresentaram PSA<0,02ng/mL, considerados como falha bioquímica. Conclusão: nossos resultados preliminares indicam uma acurácia elevada de 98% e demonstra um grande potencial de aplicação dessa nova tecnologia diagnóstica tanto no rastreamento, quanto no monitoramento do tratamento do CaP, o qual deverá ser melhor investigado em população de risco. / Introduction: prostate cancer (PCa) early diagnosis is essential to boost patients’ life expectance. Although, current biomarkers and diagnosis methods do not present reliable sensibility and specificity, making the diagnosis rather imprecise. Recent methodologies have been using circulating tumor cells (CTCs), not for screening of PCa, but as prognosis indicators, employing a vast array of techniques to capture those cells. However, the search for a new biomarkers or diagnosis methods able to screen, diagnosis, assist in prognosis and in the disease monitoring still one of the major technical and scientific objectives to be achieved. Objective: To present a new biomarker for PCa, the aptamer A4, previous screened in the prostate cancer cell line PC3, using 3DCell SELEX. And to able to detect, by flow cytometry, CTCs in blood samples of PCa patients undergoing various treatment regimen. Material and methods: the study evaluated 34 PCa patients and 16 health controls. Blood samples were collected in EDTA tubes, and after erythrocytes lysis, nucleated cells were incubated with A4 aptamer conjugated with biotin, them the cells were washed and incubated with streptavidin-FITC for later flow cytometer analysis. Percentage of CTCs were compared between patient’s groups and correlated against age, PSA levels, staging and treatment regimen (hormonal blockade, radiotherapy and surgery). Detection limit above 1% of CTCs was considered positive, based on the percentage observed on all of the 16 negative controls. Results: all patients were positively diagnosed independently of therapy time or staging, except for one patient undergoing hormonal blockade therapy, which does not present detectable CTCs. CTCs percentage presented high correlation against age (R=0.75) and with PSA levels (R=0.80) with exponential behavior, although, six patients with high CTCs count presented PSA levels <0.02 ng/mL, and were considered was biochemical errors. Conclusion: Our preliminary results indicated high accuracy (98%) and demonstrate a potential application of this technology for diagnosis and screening, as well as in the monitoring of PCa evolution, which should be better investigated in the risk population. / Dissertação (Mestrado)

CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico / A presente tese e voltada à investigação da dinâmica das partículas em um riser de leito fluidizado circulante (CFB). Os leitos fluidizados sao comumente encontrados em aplicações de diversas areas industriais, como na secagem e revestimento de partículas, na polimerizaçao, na combustao e gaseificacao de carvão ou biomassa, no craqueamento catalítico de gasóleo. Dada a importancia da compreensão fenomenologica dos mecanismos que ocorrem nestes equipamentos, este trabalho utiliza de experimentacães física material e numerica para investigar, descrever e prever o escoamento gas-solido ascendente em escala piloto. Para isso, a Unidade Piloto de Riser e Ciclones foi projetada e construída, bem como seu controle e sistema de medicão optica, a Anemometria por Efeito Doppler (PDA). O escoamento tambem foi avaliado por Fluidodinamica Computacional, como um segundo pilar sobre o qual a presente tese esta suportada, atraves da solucao de um modelo matematico euleriano-lagrangeano transiente de partícula pontual, que considera colisães entre partículas e delas com paredes rugosas do riser, implementado no codigo UNSCYFL3D. Os resultados de ambas simulacoes física material e numerica dos estudos de caso propostos, evidenciaram a formaçcaão de estruturas de macro e mesoescala, derivadas de efeitos geometricos e fluido dinâmicos, respectivamente. Ocorre segregacao do escoamento da fase sólida na base do riser e recirculacao no topo, devido a saída em T. A PDA evidenciou: a formacao da estrutura core-annulus desde a alimentacao das partículas nos maiores carregamentos, a tendâencia de segregaçcãao radial e axial de diametros de partículas e a deposiçao nas regioes próximas à parede, onde as partículas tem maior flutuacao de velocidade. As soluçoes numericas indicaram pouca influencia das forcas de Saffman e Magnus, porem grande influencia da rugosidade da parede e do efeito da turboforese. O modelo matematico foi comparado frente as mediçoes físicas, mostrando bom grau de validacao para concentraçao de partículas no centro do riser e para velocidade axial media das partículas. / This thesis is focused on the particle phase dynamics in a circulating fluidized bed riser (CFB). Fluidized beds are commonly encountered in many industrial applications such as drying and coating of particles, polimerizations, combustion and gasification of coal and biomass, gasoil fluid catalytic cracking. Given the importance of the physical understanding about CFBs, in this work experiments and simulations are carried out to explore, describe and predict the upward gas-solid flow in pilot scale. Therefore, the Pilot Unit of Riser and Cyclones was designed and built, as well as its control and optical measuring systems, the last one by using Phase Doppler Anemometry (PDA). Besides that, the flow was solved by Computational Fluid Dynamics, as the second pillar on which this thesis is based, through the solution of an Eulerian-Lagrangian unsteady point-particle model, with inter-particles collisions and impact on rough walls, implemented on the in-house code UNSCYFL3D. The results from both experiments and simulations have shown the macro- and meso-scale structures formation, caused by geometrical and fluid dynamics effects, respectively. Particle phase flow segregation occurs near the particle inlet and also recirculation at the top of the riser, due to the T shape outlet. The PDA results show the core-annulus structure formation from the bottom of the riser in the higher mass loadings, the tendency of radial and axial segregation of particle diameters and the particle deposition near the riser wall, where the discrete phase has higher velocity fluctuations. On the other hand, the simulation results show little influence of Saffman and Magnus forces over the particles flow, however great impact of the roughness wall model and of the turbophoresis effect. About the model validation, good agreement is found mainly to particle concentration at the riser centre and to the particle phase axial velocity. / Tese (Doutorado)

Introduction: Simultaneous detection of disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) was shown to be associated with an especially poor prognosis and increased incidence of disease-related deaths in non-metastatic breast cancer patients. We analyzed the occurance of DTCs in bone marrow and CTCs in peripheral blood in patients with primary breast cancer, we evaluated the correlation of their presence with other prognostic markers and we investigated the changes in DTCs/CTCs number at different time points during treatment. Materials and methods: Blood of 50 patients with primary breast cancer were used for immunomagnetic separation and detection of circulating tumor cells using the commercial available system the AdnaTest Breast Cancer™ (AdnaGen GmbH, Langenhagen, Germany). Bone marrow aspirates from 50 patients were analyzed for DTCs by immunocytochemistry using the pancytokeratin antibody conjugated with FITC (Monoclonal Anti-Cytokeratin antibody F3418, Sigma Aldrich, USA). Results: DTCs were identified in 30% (15/50) and CTCs in 22% (11/50) of patients. We found that DTC positivity could point to a significantly high risk of larger primary tumor size (p- value 0.011) and significantly higher risk of lymph node involvement (p- value 0.002). For CTC positivity, no such...

Meine Untersuchungen zeigen, dass es sich bei der zellfreien DNA (cfDNA, engl. cell-free DNA) des Spenderorgans (GcfDNA, engl. graft-derived cell-free DNA) um einen klinisch vielversprechenden Biomarker zur direkten Ermittlung der Organschädigung im Sinne einer „flüssigen Biopsie“ handelt. Alles was dafür notwendig ist, ist eine Blutprobe des Empfängerpatienten. Im Gegensatz zu konventionellen Markern wird die Organschädigung unmittelbar, direkt und hochspezifisch angezeigt. Durch neue Entwicklungen in der Labordiagnostik lässt sich dieser Marker im routinemäßigen Einsatz mittels digital droplet PCR (ddPCR) bestimmen. Die Analyseergebnisse können bei verhältnismäßig niedrigen Kosten innerhalb eines Arbeitstages erstellt werden. Unmittelbar nach Transplantation ist bei allen Patienten eine sehr hohe Konzentration der GcfDNA messbar. Innerhalb von wenigen Tagen fallen die Werte schnell ab und erreichen die Größenordnung stabiler Transplantatempfänger, die in der Lebertransplantation unter 10% liegen. Dabei besteht keine signifikante Korrelation der initialen GcfDNA-Freisetzung mit der Ischämieschädigung des Spenderorgans, ermittelt durch die Dauer der kalten Ischämiezeit (WIZ). Bei unzureichender Immunsuppression ist eine erhöhte GcfDNA-Freisetzung zu beobachten. Mithilfe der GcfDNA als Marker der Organintegrität lässt sich auch der gemeinsame Effekt verschiedener Immunsuppressiva ermitteln. Die GcfDNA verhält sich dabei umgekehrt proportional zur immunsuppressiven Therapie. Patienten mit akuten Abstoßungen haben im Mittel GcfDNA-Werte oberhalb von 50%. Die GcfDNA-Werte sind bereits mehrere Tage vor einer klinisch manifestierten akuten Abstoßung erhöht. Auch eine virusassoziierte Transplantatschädigung durch Hepatitis C manifestiert sich in vergleichsweise höheren GcfDNA-Werten. Cholestasen gehen hingegen nicht mit erhöhten GcfDNA-Werten einher. Die immunsuppressive Therapie könnte sich durch den routinemäßigen Einsatz der GcfDNA sicherer, einfacher, zuverlässiger und individueller gestalten lassen. Unter-Immunsuppressionen und daraus resultierende Abstoßungen würden sich bereits in der subklinischen Phase erkennen lassen und die Therapie von der bloßen Reaktion auf klinische Ereignisse hin zur Prävention verschieben. Um das Ziel einer personalisierten Medizin zu erreichen, könnte die Immunsuppression für jeden Patienten auf das absolut notwendige und damit gegenüber der bisherigen Praxis optimale Maß festgelegt werden. Geringere Nebenwirkungen und eine Reduktion der Kosten für das Gesundheitswesen wären die Konsequenz. Dieser Marker könnte dazu beitragen, das finale Ziel, nämlich eine Verbesserung des Langzeiterfolges nach Organtransplantationen, zu erreichen. Multizentrische Studien zur Validierung dieses Markers vor dem routinemäßigen Einsatz laufen bereits.

Foram desenvolvidos estudos de modelagem e simulação numérica de escoamentos bifásicos gás-sólido na coluna ascendente de leitos fluidizados circulantes utilizando um modelo Euleriano de duas fases separadas. O sistema de equações diferenciais parciais conservativas governantes foi obtido através de um procedimento tradicional. Ambas as fases foram assumidas como meio contínuo. Aplicou-se o procedimento de médias estatísticas de Euler, enfatizando a obtenção dos modelos hidrodinâmicos A e B desenvolvidos no IIT/ANL. Realizou-se análise comparativa de correlações para transferência de quantidade de movimento na interface. Discutiu-se a formulação de condições de contorno apropriadas. As equações diferenciais parciais médias foram discretizadas em volumes de controle Eulerianos. As equações de continuidade foram resolvidas implicitamente. As equações de quantidade de movimento foram resolvidas através de um procedimento explícito-implícito. Foram desenvolvidas simulações numéricas para uma coluna ascendente típica de leitos fluidizados circulantes. Desenvolveu-se análise paramétrica da influência de vários aspectos físicos e matemáticos sobre o escoamento. Avaliou-se resultados de simulação através de metodologia de identificação e caracterização de estruturas coerentes. Estudou-se o efeito da função de arrasto na interface sobre os processos dinâmicos que caracterizam estas estruturas coerentes. Foram realizados estudos numéricos de turbulência a partir de resultados de simulação direta. Várias conclusões e recomendações para futuros trabalhos foram propostas com base nas análises realizadas. Foram apresentadas algumas considerações gerais relativas a aspectos críticos na modelagem e simulação com modelo das duas fases separadas. / Studies were carried out on modeling and numerical simulation of gas-solid two-phase flows in the riser of circulating fluidized beds using an Eulerian two-fluids model. The system of conservative partial differential governing equations was derived through a traditional procedure. Both phases were assumed as a continuum. The Euler averaging procedure was applied emphasizing the derivation of the so called hydrodynamic models A and B developed at IIT/ANL. A comparative analysis was performed among correlations for momentum transfer at the interface. The formulation of suitable boundary conditions was discussed. The average partial differential conservative equations were discretized on Eulerian control volumes. The continuity equations were solved implicitly. The momentum equations were solved through an explicit-implicit procedure. Numerical simulation was performed for a typical circulating fluidized bed riser. A parametric analysis was carried out regarding the influence on the flow of various physical and mathematical aspects. Results of simulation were evaluated through a methodology of identification and characterization of coherent structures. The effect of the interface drag function on dynamic features of those coherent structures was addressed. Numerical studies on turbulence were performed from results of direct simulation. Several conclusions and recommendations for future work were put forward on the basis of the performed analyses. Some general considerations were presented regarding critical features of modeling and simulation through Eulerian two-fluids models.

Les métastases sont la principale cause de décès chez les patients atteints d’un cancer. Lors du développement métastatique, les cellules tumorales disséminées (CTD) doivent franchir certaines étapes clés avant de coloniser des organes distants de la tumeur primaire. Notre hypothèse est que la TNC pourrait jouer différents rôles dans la migration des cellules cancéreuses et par conséquent dans le développement métastatique. Considérant l’actine comme un réservoir de facteurs de croissance, la TNC pourrait induire la TEM ainsi que la survie et l’extravasation des cellules tumorales. Cependant, des cellules cancéreuses individualisées localement pourraient répondre à la TNC en initiant des changements rapides menant à un phénotype migratoire de type amiboïde. L’objectif de cette thèse a été d’étudier comment la TNC stimule le développement métastatique dans le cancer du sein au niveau cellulaire et moléculaire en utilisant des modèles tumoraux et cellulaires. / A high TNC expression correlates with lung metastagenicity and was shown to promote experimental lung metastasis, but the underlying mechanisms are poorly understood. The results of my thesis have provided insight into the roles of TNC in metastasis suggesting that TNC contributes to extravasation by impacting on survival, endothelialization, EMT and migration. Moreover, I have identified TGF-β signaling and integrin α9β1 as important pathway and molecule, respectively to be employed by TNC. Whether both molecule/pathway play a similar role in the investigated models of breast cancer, osteosarcoma and glioblastoma remains to be seen.

La diffusion dans le sang des cellules tumorales circulantes (CTC) à partir de la tumeur primitive est un signe précoce d’invasivité tumorale et du risque de développer des métastases. Par conséquent, la capacité à les détecter de façon très sensible et spécifique est censée constituer un test cliniquement important pour le pronostic du cancer, le suivi des patients et la personnalisation de la thérapie. Les CTC sont des cellules rares, et plusieurs méthodes ont été proposées pour leur détection. La technique ISET (Isolation by Size of Epithelial/Tumor cells) se base sur la différence de taille des CTC par rapport aux cellules leucocytaires et a montré une très grande sensibilité d’isolement et spécificité d’identification des CTC. Elle permet l’analyse cytopathologique, immunologique et moléculaire des cellules isolées.Le cancer du rein représente 3% des cancers de l’adulte, dans 75% des cas il s’agit d’un carcinome rénal à cellules claires (RCC). Sur le plan génétique, il est un des rarissimes cancers solides caractérisé par des variations de l’ADN, il s’agit de mutations au niveau du gène VHL.Ce projet de recherche vise l’analyse comparative, moléculaire et cytopathologique, des CTC isolées à partir des patients avec RCC dans le but d’évaluer, par une approche moléculaire, les critères cytopathologiques diagnostiques des CTC. Notre étude a porté sur 29 patients ayant bénéficié de l’isolement des CTC par ISET avant toute intervention chirurgicale.L’analyse cytopathologique a été réalisée utilisant les critères décrits par l’équipe de P. Hofman pour définir les CTC (CNHC-MF) et les Cellules Atypiques Circulantes « CAC » (CNHC-UMF). L’analyse génétique par séquençage du gène VHL a été réalisée avec succès sur l’ADN de 205 cellules individuelles, sur l’ADN issu du tissu tumoral et sur l’ADN génomique de chaque patient.Sur les 29 tumeurs étudiées, 25 étaient caractérisées par des mutations du gène VHL. Cent soixante et une cellules, CTC et CAC, isolées à partir du sang de ces 25 patients, ont présenté des variations génétiques du gène VHL identiques à l’ADN issu du tissu tumoral. Il s’agit de 18 mutations différentes affectant les 3 exons de ce gène. Nous avons trouvé des CTC/CAC dans 29/30 des patients avec CCRC analysés. Des mutations VHL ont été trouvées dans 25 des 29 tumeurs CCRC correspondantes. Nous avons obtenu des résultats spécifiques VHL dans 205 des 327 CTC/CAC microdisséquées, comprenant 64 CTC et 141 CAC, selon l’analyse cytopathologique. Les mutations VHL ont été détectées en aveugle dans 57/64 CTC et dans 125/141 CAC. Cependant, nous avons observé que les 8 et 16 CTC et CAC restantes, respectivement, avaient été isolées de patients sans mutations VHL détectables dans le tissu tumoral.Conclusion : Ceci est la première étude comparative de diagnostic génétique et cytopathologique des CTC/CAC chez des patients avec un cancer solide, le CRCC. Nos résultats suggèrent que des critères cytopathologiques élargis pourraient être appliqués au diagnostic des CTC chez les patients avec CCRC. Bien que des études complémentaires et plus élargies soient maintenant nécessaires, cette méthode ouvre la voie à une approche génétique pour le diagnostic des Cellules Tumorales Circulantes / Dissemination in the circulating tumor cells (CTC) from the primary tumor is an early sign of tumor invasion and risk of metastases. Therefore, the ability to detect CTC through a very sensitive and specific test is expected to be clinically important for cancer prognosis, patient monitoring and customization of therapy. CTCs are rare cells, and several methods have been proposed for their detection. The ISET technique (Isolation by Size of Epithelial /Tumor cells) is based on the difference in size of CTC as compared to leucocytes and provides high sensitivity of CTC isolation and high specificity of CTC identification. This methods also allows cytopathological, immunological and molecular analyses of the isolated cellsKidney cancer accounts for 3% of adult cancers and is a clear cell renal cell carcinoma (RCC) in 75% of cases. RCC is one of very rare cancers characterized by a DNA mutations. IRCC tumor cells are in fact characterized by by mutations in the VHL gene. This research project aims at a comparative molecular and cytopathological analysis of, CTCs isolated from patients with RCC in order to evaluate, through a molecular approach, the diagnostic criteria used for cytopathological identification of CTC. Our study included 29 patients tested by the ISET technique before surgery.The cytopathological analysis was performed using the criteria described by the group of P. Hofman to define CTC (CNHC-MF) and Circulating Atypical Cells "CAC" (UMF-CNHC). Genetic analysis of the VHL gene was successfully performed by sequencing on DNA from 205 individual cells isolated by ISET, on DNA from tumor tissue and on genomic DNA from each patient. Of the 29 tumors studied, 25 were characterized by mutations in the VHL gene. One hundred and sixty-one cells, CTC and CAC, isolated from the blood of the 25 patients, with the tumor having VHL mutation, showed genetic variations in the VHL gene identical to those found in the DNA from the tumor tissue. We found 18 different mutations affecting the three exons of this gene.We found CTC/CAC in 29/30 analyzed patients with CCRC. VHL mutations were found in the tumor of 25 out of the corresponding 29 CCRC tumors. Among 327 microdissected CTC/CAC, we obtained VHL-specific results in 205 including 64 CTC and 141 CAC, according to the cytopathological analysis. VHL mutations were blindly detected in 57/64 CTC and in 125/141 CAC. However, we then observed that the 8 and 16 residual CTC and CAC, respectively, had been isolated from patients without detectable VHL mutations in the tumor tissue. Conclusion: This is the first study comparing genetic and cytopathological diagnosis of CTC/CAC in patients with a solid cancer, CRCC. Our results suggest that broaden cytopathological criteria could be applied to the diagnosis of CTC in patients with CCRC. Although further and larger studies are now needed, this approach opens the way to a genetic approach for the accurate diagnosis of Circulating Tumor Cells.

The objective of the research is to design an electro-optic control for the Active Vertical Coupler-based Optical Cross-point Switch (OXS). The electronic control should be implemented on Printed Circuit Board (PCB) and therefore the design will include the PCB design as well. The aim of the electronic control board is to process the headers of the packets prior to entering the OXS to be switched and from the information in the headers, determine the state that the OXS should be configured in. It should then configure the optical cross-point accordingly. The electronic control board should show flexibility in the sense that it can handle different types of traffic and resolve possible contention that may occur. The research seeks to understand the problems associated with Photonic Packet Switching (PPS) networks. Two of the main problems identified in a PPS network are contention resolution and the lack of variable delays for storing optical packets. The OXS was analyzed and found to meet the requirements for future ultra-high speed PPS network technology with its high extinction ratio, wide optical bandwidth, ultra-fast switching speed and low crosstalk levels. Photonic packets were generated with 4-bit, 8-bit or 16-bit headers at a bit rate of 155 Mbit/s followed by a PRBS (Pseudo Random Bit Sequence) payload at 10 Gbit/s. Different scenarios were created with these types of packets and the electro-optic control and OXS were subjected to these scenarios with the aim of testing the flexibility of the electro-optic control to control the OXS. These scenarios include: <ul><li>Fixed length packets arriving synchronously at one input of the OXS. Some packets are destined for output 1, some are destined for output 2 and some are destined for output 3, therefore realizing a 1-to-3 optical switch.</li> <li>Eight variable length packets arriving synchronously at the OXS at one input, all of them destined for one output. The electro-optic control should open the switch cell for the correct amount of time.</li> <li>Three variable length packets arriving synchronously and asynchronously at one input of the OXS. Some packets are destined for output 1 while other packets are destined for output 2. The electro-optic control should open the correct switch cell for the correct amount of time.</li> <li>Two fixed length packets arriving at the OXS synchronously on different input ports at the same time, both destined for the same output port. The electro-optic control should detect the contention and switch the packets in such a way as to resolve the contention.</li> The electro-optic control and OXS managed to switch all these types of data traffic (scenarios) successfully and resolve the contention with an optical delay buffer. The success of the results was measured in two ways. Firstly it was deemed successful if the expected output sequence was measured at the corresponding output ports. Secondly it was successful if the degradation in quality of the packet was not drastic, meaning the output packets should have an BER (Bit Error Rate) of less than 10-9. The quality of the packets was measured in the form of eye diagrams before and after the switching and then compared. The research resulted in the design and implementation of a flexible electro-optic control for the OXS. The problem of contention was resolved for fixed length synchronous packets and a proposal is discussed to store packets for variable lengths of time by using the OXS. This electro-optic control has the potential to control the OXS for traffic with higher complexities and make the OXS compatible with future developments. / Dissertation (MEng (Electronic Engineering))--University of Pretoria, 2008. / Electrical, Electronic and Computer Engineering / MEng / unrestricted

Objective: We aimed to assess the prognostic value of circulating tumor cells (CTC) in patients with advanced gastric and gastroesophageal adenocarcinomas. Methods: The presence of CTC was evaluated in 62 patients with advanced gastric and gastroesophageal adenocarcinomas before systemic therapy and at follow-up through immunomagnetic enrichment for mucin 1- and epithelial cell adhesion molecule (EpCAM)-positive cells, followed by real-time RT-PCR of the tumor-associated genes KRT19 , MUC1 , EPCAM , CEACAM5 and BIRC5 . Results: The patients were stratified into groups according to CTC detection (CTC negative: with all marker genes negative; CTC positive: with at least 1 of the marker genes positive). Patients who were CTC positive at baseline had a significantly shorter median progression-free survival (PFS; 3.5 months, 95% CI: 2.9–4.2) and overall survival (OS; 5.8 months, 95% CI: 4.5–7.0) than patients lacking CTC (PFS 10.7 months, 95% CI: 6.9–14.4, p < 0.001; OS 13.3 months, 95% CI: 8.0–18.6, p = 0.003). Alterations in the marker profile during the course of chemotherapy were not predictive of clinical outcome or response to therapy. Yet, a favorable clinical response depended significantly on CTC negativity (p = 0.03). Conclusion: Our data suggest that the presence of CTC is a major predictor of outcome in patients with gastric and gastroesophageal malignancies.